BSL3/2 Testing Services

We have the expertise and experience to help get you the testing you need.

Innovative Bioanalysis, Inc. experts can help design a (Biosafety Level 3) BSL3 chamber test protocol to simulate a “real world” application. With hundreds of successful device efficacy tests against surface and aerosol pathogens including SARS-CoV-2, we have the expertise and experience to help get you the testing you need. We look forward to helping you through the process of understanding the multiple testing options and evaluating the best option for your device and goals. 

Innovative Bioanalysis
Innovative Bioanalysis
Innovative Bioanalysis
Innovative Bioanalysis
Innovative Bioanalysis
Innovative Bioanalysis
Air Purifier/Cleaner Devices
Air Purifier/Cleaner Devices
ASHRAE Standards Testing
ASHRAE Standards Testing
Efficacy Testing – Surface
Efficacy Testing – Surface
Efficacy Testing – Aerosol
Efficacy Testing – Aerosol
SARS-CoV-2 (COVID-19)
SARS-CoV-2 (COVID-19)
Other Pathogens
Other Pathogens

Biosafety level 3 (BSL-3)

Biosafety level 3 (BSL-3) is applicable to laboratories where work is performed with pathogens that may cause serious or potentially lethal disease through inhalation, to the personnel, and may contaminate the environment. It requires that laboratory personnel receive specific training in handling pathogenic and potentially lethal agents and be supervised by scientists competent in handling infectious agents and associated procedures. All work is performed in contained environments using appropriate engineering controls. Access to a BSL-3 laboratory is restricted and always controlled.

Biosafety level 2 (BSL-2)

Biosafety level 2 (BSL-2) laboratory involves working with agents that pose moderate hazards to personnel and the environment. Basic laboratory with restricted access and containment during certain processes is required. Use of autoclaves and biological safety cabinets is desired. Use of good laboratory practices, safe waste disposal measures, and aseptic techniques are mandatory. Usually non-respiratory, non-lethal agents are handled in BSL-2 laboratory. Access to a BSL-2 lab is restricted. Outside personnel are often restricted from entering when work is being conducted.

Air Purifier/Cleaner Devices

Air Purifier/Cleaner Devices

Air cleaners and HVAC filters are designed to filter or inactivate pollutants or contaminants out of the air that pass thru them. Air cleaning and filtration can help reduce airborne contaminants, including particles containing viruses. Portable air cleaners (also known as air purifiers) may be particularly helpful when additional ventilation with outdoor air is not possible without compromising indoor comfort (temperature or humidity), or when outdoor air pollution is high.

Germicidal Ultraviolet (UVGI):

Germicidal ultraviolet (UVGI) lamps have a long history of use for inactivating microbial aerosol pathogens. Ventilation duct use of UVGI has been increasing ever since the COVID-19 pandemic started. Innovative Bioanalysis specializes in creating custom BSL3 chamber testing based on modified ASHRAE and ISO standards to simulate real world applications of UVGI lamps to inactivate aerosolized pathogens in ventilation ducts or for in-room device.

Ionization:

The effectiveness of bipolar ionization in cleaning air is nothing new. As far back as 1966, the ASHRAE Journal was promoting the benefits of ionization. Even at that time, hundreds of studies already proved the value of ionization as one tool in a combined approach to improving indoor air quality. Innovative Bioanalysis, Inc. specializes in creating custom BSL3 chamber testing based on modified ASHRAE and ISO standards to simulate real world applications of ionization to inactivate aerosolized pathogens in ventilation ducts or for in-room device.

ASHRAE Standards Testing

ASHRAE Standards Testing

Since the pandemic, multiple standards have been created for testing of the effectiveness of air cleaning systems. Innovative Bioanalysis has been actively involved with helping as Committee members or consultants on developing many of these Standards. If you are interested in learning more about which standards would best apply to your air purification device, please contact us.

Current and future efficacy standards include:

  • ASHRAE 241, Control of Infectious Aerosols
  • ANSI/AHAM AC-5, Method For Assessing The Reduction Rate Of Key Bioaerosols By Portable Air Cleaners Using An Aerobiology Test Chamber
  • ANSI/ASHRAE 185.1, Method of Testing UV-C Lights for Use in Air-Handling Units or Air Ducts to Inactivate Airborne Microorganisms (ANSI Approved)
  • ANSI/ASHRAE 185.3P (Proposed), Method of Testing In-Room Devices and Systems for Microorganism Removal or Inactivation in a Chamber
  • ANSI/ASHRAE 185.4P (Proposed), Method of Testing In-Room Ultraviolet Devices and Systems for Microbial Inactivation on Surfaces in a Test Room.
ASHRAE 185.3P
ASHRAE 241

Efficacy Testing – Surface

All products designed to protect against viruses, bacteria, fungi and other pathogens should have testing data proving their ability to kill these pathogens.

Innovative Bioanalysis’ experts can help design a (Biosafety Level 3) BSL3 chamber test protocol to simulate a “real world” application. With hundreds of successful device efficacy tests against surface pathogens, we have the experience and expertise to help get you the data you need. We look forward to helping you through the process of understanding the testing options and evaluating the best test for your device.

Surface efficacy testing benefits:

  • Provides evidence of product performance
  • Gain the competitive edge with reliable, third-party validation
  • Supports consumer confidence in product capabilities
  • Data provided may be used to seek regulatory approval
Efficacy Testing – Aerosol

Efficacy Testing - Aerosol

All products designed to protect against viruses, bacteria, fungi and other pathogens should have testing data proving their ability to kill these pathogens. 

Infectious pathogens are most dangerous when transmitted through the air. They are invisible to the naked eye and exist everywhere. If an infected person sneezes or coughs, they produce a cloud of infectious particles, resulting in the potential exposure of susceptible persons within the same area. There are limited options when trying to control viruses and bacteria once it has been aerosolized.

The following list below includes some of the microorganisms that are pathogenic and have the potential to become aerosolized:

  • SARS-CoV-2, BSL3 virus that causes COVID-19
  • Influenza A & B, BSL3 virus that causes the flu
  • Rhinovirus, BSL2 virus that causes the common cold
  • Mycobacterium tuberculosis (TB), BSL2 bacteria
  • Bordetella pertussis, Whooping cough
  • Haemophilus influenzae, bacterial pathogen
  • Pseudomonas aeruginosa, bacteria
  • Aspergillus, fungus

For more information about the many different bacteria, viruses, and fungal species that are aerosolized at the lab, contact the laboratory and speak with our team.

Innovative Bioanalysis’ experts can help design a (Biosafety Level 3) BSL3 chamber test protocol to simulate a “real world” application of your device. With hundreds of successful device efficacy tests against aerosol pathogens, we have the expertise and experience to help get you get the data you need. We look forward to helping you through the process of understanding the testing options and evaluating the best test for your device.

Aersosol efficacy testing benefits:

  • Provides evidence of product performance
  • Gain the competitive edge with reliable, third-party validation
  • Supports consumer confidence in product capabilities
  • Data provided may be used to seek regulatory approval

SARS-CoV-2 (COVID-19)

The American Biological Safety Association (ABSA) has published a useful reference chart explaining the CDC & WHO guidance for handling SARS-CoV-2 (COVID-19) samples by categorizing specific laboratory procedures and the appropriate BSL requirements. The ABSA document discusses practices and techniques, PPE as well as suggested administrative controls.

Download the PDF
Other Pathogens

Other Pathogens